Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Seminars in Arthritis and Rheumatism|September 10, 2013
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugsDaniel H Solomon, Joel M Kremer, Mark Fisher, et al.
Annals of the Rheumatic Diseases|October 5, 2013
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis riskAnnie Yarwood, Buhm Han, Soumya Raychaudhuri, et al.
BMC Musculoskeletal Disorders|March 16, 2017
Sex differences in gout characteristics: tailoring care for women and menLeslie R Harrold, Carol J Etzel, Allan Gibofsky, et al.
BMC Musculoskeletal Disorders|November 23, 2014
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology networkLeslie R Harrold, George W Reed, J Timothy Harrington, et al.
Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
Rheumatology International|July 20, 2019
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world settingPhilip J Mease, Neil A Accortt, Sabrina Rebello, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritisJeremy Sokolove, Vibeke Strand, Jeffrey D Greenberg, et al.
The Journal of Rheumatology|January 17, 2013
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritisEsi Morgan Dewitt, Yanhong Li, Jeffrey R Curtis, et al.
The Journal of Rheumatology|November 3, 2015
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort StudyKazuki Yoshida, Helga Radner, Maria D Mjaavatten, et al.
The Journal of Rheumatology|September 17, 2010
Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registrySoumya M Reddy, Allen P Anandarajah, Mark C Fisher, et al.
Pageof 12